Skip to content
Menu
Ranked #194

MedLeanRx

MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.

Desk Score 69/100 (C) · Verified July 2026

Visit MedLeanRxAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is MedLeanRx legit?

Only what MedLeanRx publishes and what we could check ourselves — nothing inferred. See the methodology.

Certification
MedLeanRx publishes a LegitScript certification on its own pages.
Where it ships
1 state, as published on the site.
Last checked
July 2026, against MedLeanRx's own pages.
Published price
MedLeanRx publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does MedLeanRx cost?" below.
What it sells
Brand-name medication as well as compounded, injectable and oral routes.
Licensing & trust
74/100 on the scored dimension of that name — one of the six in our published methodology.

Checks out as far as the figures go, with one caveat: every price MedLeanRx publishes carries a condition, so the number on the site is not the monthly bill.

What does MedLeanRx cost?

Each figure exactly as MedLeanRx publishes it, with the condition attached to it spelled out.

Semaglutide

$149/mo (starting dose, promotional rate, compounded)

That is a promotional rate: $149 a month is an introductory figure rather than the standing one.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for semaglutide — only flat month-to-month rates compete there.

Tirzepatide

$269/mo (starting dose, compounded)

That is a starting figure, not the price at every dose: $269 a month is the lowest rung, and the cost rises from there.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for tirzepatide — only flat month-to-month rates compete there.

All figures as published on MedLeanRx's own site and read in July 2026. Prices change — confirm before you order.

Semaglutide
$149/mopromo rate
Tirzepatide
From $269/molowest dose rung
Coverage
1 state
Brand-name
Yes
Verification
Prices as published on MedLeanRx's site — verified july 2026. Each figure's full condition is in “What does MedLeanRx cost?” below.

Weigh MedLeanRx against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: MedLeanRx vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency78/100
State access42/100
Molecule range95/100
Onboarding speed52/100
Support responsiveness70/100
Licensing & trust74/100

What we like

  • Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
  • Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
  • Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
  • LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
  • Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips

Where points come off

  • Texas only — not available in the other 49 states
  • Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
  • Strict no-refund policy: 'All sales are final' per Terms & Conditions
  • Pharmacy partner not publicly named — a transparency gap for a compounding service
  • Legal entity name and founding details not published on the site

The bottom line — C

Best for: Texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway.

MedLeanRx ranks #194 of 542 providers scored — see #1, CoreAge Rx here.

Related reviews

Everyone else here (24)

Pricing and verification reflect MedLeanRx's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on MedLeanRx's site. Not medical advice; see our disclosure.

← Back to the ranking